Chen, C. D., McCullough, A., Gordon, B., Joseph-Mathurin, N., Flores, S., McKay, N. S., Hobbs, D. A., Hornbeck, R., Fagan, A. M., Cruchaga, C., Goate, A. M., Perrin, R. J., Wang, G., Li, Y., Shi, X., Xiong, C., Pontecorvo, M. J., Klein, G., … Su, Y. (2023). Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer’s disease. European Journal of Nuclear Medicine and Molecular Imaging, 50(9), 2669–2682. https://doi.org/10.1007/s00259-023-06209-0
Columbia Affiliation:
Subjects:
Alzheimer Disease
(MeSH)
Grants:
K01AG080123
(NIH – National Institute On Aging)
P30AG066462
(NIH – National Institute On Aging)
P30AG066508
(NIH – National Institute On Aging)
P30AG072980
(NIH – National Institute On Aging)
P30NS098577
(NIH – National Institute of Neurological Disorders and Stroke)
R01AG046179
(NIH – National Institute On Aging)
R01AG052550
(NIH – National Institute On Aging)
R01AG053267
(NIH – National Institute On Aging)
R01AG068319
(NIH – National Institute On Aging)
S10OD025214
(NIH – Office of the Director, National Institutes of Health)
T32AG058518
(NIH – National Institute On Aging)
U01AG042791
(NIH – National Institute On Aging)
U19AG032438
(NIH – National Institute On Aging)
UF1AG032438
(NIH – National Institute On Aging)
UL1TR001863
(NIH – National Center for Advancing Translational Sciences)
Publication Type:
Article
Unique ID:
10.1007/s00259-023-06209-0
PMID:
Publication Date:
Data Source:
PubMed
Source Link: